Holen Sie sich die Stockscreener-App
78.11
1.92%
1.47
Handel nachbörslich:
78.11
Schlusskurs vom Vortag:
$76.64
Offen:
$76.7
24-Stunden-Volumen:
1.55M
Relative Volume:
0.92
Marktkapitalisierung:
$10.60B
Einnahmen:
$3.10B
Nettoeinkommen (Verlust:
$586.71M
KGV:
18.19
EPS:
4.2937
Netto-Cashflow:
$605.57M
1W Leistung:
-2.51%
1M Leistung:
-3.40%
6M Leistung:
-17.32%
1J Leistung:
+35.14%
1-Tages-Spanne:
$76.07
$78.79
1-Wochen-Bereich:
$74.94
$82.04
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
78.11 | 10.60B | 3.10B | 586.71M | 605.57M | 4.2937 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | Needham | Hold → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
GMED stock holds steady on Globus Medical's business profile - ad-hoc-news.de
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGR - GlobeNewswire Inc.
Globus Medical IncA (NYSE:GMED) Screens Well as a GARP Stock with Strong Growth and Reasonable Valuation - ChartMill
BMO Capital Maintains Globus Medical(GMED.US) With Buy Rating, Cuts Target Price to $94 - Moomoo
Intuitive, Globus, Teleflex named top picks at BMO (ISRG:NASDAQ) - Seeking Alpha
BMO Capital Initiates Globus Medical at Outperform With $94 Price Target - marketscreener.com
Stifel Maintains Globus Medical(GMED.US) With Hold Rating, Cuts Target Price to $80 - Moomoo
A Look at Globus Medical Inc (GMED) After 3.3% Decline -- GF Val - GuruFocus
Globus Medical (GMED) Receives Positive Coverage from BMO Capita - GuruFocus
Stifel cuts Globus Medical stock price target on growth concerns - Investing.com
Stifel cuts Globus Medical stock price target on growth concerns By Investing.com - Investing.com India
Globus Medical (GMED) Rose With Device Stocks, Is It Still 27% Undervalued? - Yahoo Finance
What Globus Medical (GMED)'s Robotics-Focused Institutional Interest Means For Shareholders - Sahm
Globus Medical Inc focuses on spine technologies as investors watch long term growth - ad-hoc-news.de
Earnings call transcript: Globus Medical Q1 2026 beats forecasts, stock dips - Investing.com
Globus Medical (GMED) Secures FDA Clearances As Revenue And R And D Stay Strong - Sahm
Price to earnings forward of Globus Medical, Inc. – NYSE:GMED - TradingView
Enterprise value to revenue forward of Globus Medical, Inc. – NYSE:GMED - TradingView
Globus Medical (NYSE:GMED) Shines in Navellier’s Little Book Growth Stock Screen - ChartMill
Globus Medical Inc (GMED) Shares Fall 5.9% -- What GF Score of 9 - GuruFocus
Globus Medical Drops 7.0% Amid Sector-Wide Selling - AlphaStreet
GMED vs. MDT: Which Medical Stock Has More Upside Potential? - Yahoo Finance
Globus Medical Inc Class A Actuals & Estimates (GETTEX:GM0N) - TradingView
Globus Medical Inc Class A Actuals & Estimates (FWB:GM0N) - TradingView
Globus Medical Inc Class A Actuals & Estimates (HAM:GM0N) - TradingView
Price to sales forward of Globus Medical Inc Class A – TRADEGATE:GM0N - TradingView
Globus Medical (GMED) Stock After 47% One-Year Gain Is There More Room To Run - Yahoo! Finance Canada
Globus Medical Inc Class A Actuals & Estimates (XETR:GM0N) - TradingView
Globus Medical Inc Class A Actuals & Estimates (BMV:GMED) - TradingView
GM0N Forecast — Price Target — Prediction for 2027 - TradingView
Globus Medical Inc Class A Actuals & Estimates (TRADEGATE:GM0N) - TradingView
Globus Medical Inc Class A Actuals & Estimates (NYSE:GMED) - TradingView
How Globus Medical Inc. Class A (GMED) Affects Rotational Strategy Timing - Stock Traders Daily
Globus Medical updates guidance after NuVasive merger close, shares react on NASDAQ - Ad-hoc-news.de
Globus Medical Inc Class A Actuals & Estimates (BX:GMED) - TradingView
Globus Medical Inc Class A Actuals & Estimates (DUS:GM0N) - TradingView
Globus Medical Inc Class A Actuals & Estimates (BOATS:GMED) - TradingView
A Look at Globus Medical Inc (GMED) After 3.1% Gain -- GF Value $98.62 vs Price $84.65 - GuruFocus
Globus Medical Inc Class A Actuals & Estimates (BIVA:GMED) - TradingView
GMED Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Globus Medical Inc Class A – BIVA:GMED - TradingView
Enterprise value to EBITDA forward of Globus Medical, Inc. – NYSE:GMED - TradingView
Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on May 15, 2025. - marketscreener.com
Earnings Beat Amid Currency Headwinds Might Change The Case For Investing In Globus Medical (GMED) - Sahm
BTIG Maintains Globus Medical(GMED.US) With Hold Rating - Moomoo
ExcelsiusGPS from Globus Medical Inc.robotic spine platform gains traction in US hospitals - AD HOC NEWS
Globus Medical’s Q1 Beat and FX Pressures Might Change The Case For Investing In GMED - Yahoo Finance
Globus Medical (GMED) Surges 5.1%: Is This an Indication of Further Gains? - Yahoo Finance
Globus Medical (GMED) Stock Could Be 28% Undervalued Despite Recent Share Price Bounce - Sahm
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $103 to $120 - Moomoo
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):